In a new study, many cancer patients reported significant improvements in sleep disruptions and a decreased use of other medication for insomnia.
This workshop will provide a broad perspective of the current knowledge of elemental contaminants in cannabis/hemp consumer products, communicate their significance, and as a result, educate users, cultivators, processors, testing labs, and regulators within the cannabis/hemp community of their potential risk to human and environmental health.
The Nevada Cannabis Compliance Board (CCB) are considering changes to its state cannabis regulations which would remove the requirement for cannabis treated with irradiation to display the international symbol for irradiation, the Radura.
In a new meta-analysis of past cannabis impairment studies, researchers at the University of Sydney have identified a “window of impairment” following medium and high-dose cannabis use, during which users should avoid driving.
The paper found that, while cannabis consumers have higher rates of psychotic experiences than non-consumers, the difference was indeed more pronounced among those with a high genetic predisposition to schizophrenia.
Both the cannabis users and non-users showed similar resting heart rates and blood pressure levels, but the study’s authors are still concerned that even young cannabis consumers have an elevated risk of developing cardiovascular disease.
Teens who frequently see billboard or storefront advertising for recreational cannabis products are more likely to use the drug weekly and to have symptoms of cannabis use disorder, according to new research.